Efficacy and Safety of Adding Azarga to Prostaglandin Monotherapy

Phase 4 Completed 47 enrolled Alcon Research

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the safety and efficacy of adding AZARGA in glaucoma patients with uncontrolled intraocular pressure (IOP), currently on prostaglandin monotherapy.

Timeline

Start: 2009-07
Primary completion: 2010-08
Completion: 2010-08

Publications

Results Lorenz K, Rosbach K, Matt A, Pfeiffer N. Addition of a fixed combination of brinzolamide 1%/timolol 0.5% to prostaglandin monotherapy in patients with glaucoma or ocular hypertension. Clin Ophthalmol. 2011;5:1745-50. doi: 10.2147/OPTH.S25987. Epub 2011 Dec 9.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Brinzolamide/Timolol	Unknown	0.5 %	Topical
Subject	Brinzolamide/Timolol	Unknown	1 %	Topical

Efficacy and Safety of Adding Azarga to Prostaglandin Monotherapy

Summary

Timeline

Publications

Drugs

Indications